![]() |
Volumn 69, Issue 1, 2015, Pages 123-139
|
Industry perspective on the medical risk of visible particles in injectable drug products
a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG;
DRUG CONTAMINATION;
DRUG INDUSTRY;
HUMAN;
INJECTION;
INTRAVENOUS DRUG ADMINISTRATION;
PARTICLE SIZE;
PREVENTION AND CONTROL;
RISK FACTOR;
STANDARDS;
DRUG CONTAMINATION;
DRUG INDUSTRY;
HUMANS;
INFUSIONS, INTRAVENOUS;
INJECTIONS;
PARTICLE SIZE;
PHARMACEUTICAL PREPARATIONS;
RISK FACTORS;
|
EID: 85016001764
PISSN: None
EISSN: 19482124
Source Type: Journal
DOI: 10.5731/pdajpst.2015.01037 Document Type: Review |
Times cited : (53)
|
References (0)
|